Zydus Lifscience Gets CDSCO Panel Nod to Manufacture, Market Nivolumab for Metastatic Non-small Cell Lung Cancer Dr. Divya Colin7 July 2024 6:00 PM ISTNew Delhi: In a significant development, the drug major Zydus Life Sciences has got the go-ahead from the Subject Expert Committee (SEC) functional...
Zydus Lifesciences BP lowering drug receives USFDA tentative nod Ruchika Sharma4 July 2024 4:46 PM ISTAhmedabad: Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration (USFDA) to market...
Zydus Lifesciences bags USFDA tentative nod for Azilsartan Medoxomil and Chlorthalidone Tablets for hypertension Ruchika Sharma14 Jun 2024 4:02 PM ISTAhmedabad: Zydus Lifesciences Limited has announced that the Company has received tentative approval from the United States Food and Drug...
Zydus Lifesciences gets USFDA nod for asthma drug Theophylline ER Ruchika Sharma22 May 2024 3:45 PM ISTAhmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to market Theophylline...
Zydus Lifesciences appoints Shelina Parikh as Additional Director, Independent Director Ruchika Sharma18 May 2024 1:30 PM ISTAhmedabad: Zydus Lifesciences has approved the appointment of Shelina Parikh as an Additional Director as well as Independent Director of the...
Zydus Lifesciences arm, MSN Labs collaborate to license, supply cancer drug Cabozantinib in US Ruchika Sharma18 May 2024 12:27 PM ISTAhmedabad: Zydus Lifesciences Ltd., a global innovation driven healthcare company has announced that its wholly owned subsidiary, Zydus...
Zydus Lifesciences Dexamethasone Tablets bags USFDA okay Ruchika Sharma13 May 2024 11:22 AM ISTAhmedabad: Zydus Lifesciences Limited has announced that the Company has received final approval from the United States Food and Drug...
Zydus Lifesciences completes enrolment for EPICS III Phase 2b/3 trial evaluating Saroglitazar Mg for Primary Biliary Cholangitis Ruchika Sharma10 May 2024 11:56 AM ISTSaroglitazar Mg is a potent and selective peroxisome proliferator-activated receptor alpha and gamma dual agonist.
CDSCO Panel grants Zydus Lifscience Proposal For Additional Indication of Trivalent Influenza vaccine in 6 months to 17 years age Dr. Divya Colin9 May 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved Zydus Lifscience's...
Dr Reddy's Labs expects strong product pipeline in North America for FY25 Ruchika Sharma9 May 2024 5:47 PM ISTBengaluru: Dr. Reddy's Laboratories, based in India, forecasts a strong product lineup for its key market in North America in the fiscal year...
Zydus Lifesciences bags USFDA nod for Dapsone Gel for acne treatment Ruchika Sharma9 May 2024 2:52 PM ISTAhmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to market Dapsone...
Sentynl Therapeutics, a Zydus company acquires Zokinvy for Progeria from Eiger Biopharma Ruchika Sharma5 May 2024 12:00 PM ISTAhmedabad: Sentynl Therapeutics, Inc., a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences Ltd. (Zydus Group), and Eiger...
